Search by Drug Name or NDC
NDC 71406-0105-01 Senna 8.6 mg/1 Details
Senna 8.6 mg/1
Senna is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by AACE PHARMACEUTICALS, INC.. The primary component is SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 71406-0105-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 71406-0105 |
|---|---|
| Product ID | 71406-105_0d0b0996-208f-e38b-e063-6294a90ae522 |
| Associated GPIs | 46200060200303 |
| GCN Sequence Number | 019964 |
| GCN Sequence Number Description | sennosides TABLET 8.6 MG ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 00701 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Generic |
| Proprietary Name | Senna |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sennosides 8.6 mg Tablets |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8.6 |
| Active Ingredient Units | mg/1 |
| Substance Name | SENNOSIDES |
| Labeler Name | AACE PHARMACEUTICALS, INC. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M007 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71406-0105-01 (71406010501)
| NDC Package Code | 71406-105-01 |
|---|---|
| Billing NDC | 71406010501 |
| Package | 100 TABLET in 1 BOTTLE, PLASTIC (71406-105-01) |
| Marketing Start Date | 2019-08-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |